Association of Polyp Regression after Loading Phase with 12-Month Outcomes of Eyes with Polypoidal Choroidal Vasculopathy.

Pharmaceuticals (Basel) · 2024 · PMC11206239 · PMID 38931354

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

did not reach statistical significancep = 0.053so close (0.05 < p ≤ 0.1)

However, BCVA in the complete regression group treated with aflibercept did not reach statistical significance (from 0.30 ± 0.26 logMAR to 0.25 ± 0.36 logMAR, p = 0.053).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.